Ascending aortic dilation in patients with congenital complete heart block
- 1 December 2008
- journal article
- research article
- Published by Elsevier in Heart Rhythm
- Vol. 5 (12) , 1704-1708
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Angiotensin II Blockade and Aortic-Root Dilation in Marfan's SyndromeNew England Journal of Medicine, 2008
- Long-Term Doxycycline Is More Effective Than Atenolol to Prevent Thoracic Aortic Aneurysm in Marfan Syndrome Through the Inhibition of Matrix Metalloproteinase-2 and -9Circulation Research, 2008
- ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart DiseaseCirculation, 2006
- Losartan, an AT1 Antagonist, Prevents Aortic Aneurysm in a Mouse Model of Marfan SyndromeScience, 2006
- Recommendations for Chamber Quantification: A Report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, Developed in Conjunction with the European Association of Echocardiography, a Branch of the European Society of CardiologyJournal of the American Society of Echocardiography, 2005
- Theoretical and empirical derivation of cardiovascular allometric relationships in childrenJournal of Applied Physiology, 2005
- Endocardial fibroelastosis associated with maternal anti-Ro and anti-La antibodies in the absence of atrioventricular blockJACC, 2002
- Isolated Congenital Complete Atrioventricular Block in Adult LifeCirculation, 1995
- Antibody Mediated Complete Congenital Heart Block in the FetusPacing and Clinical Electrophysiology, 1993
- Complete congenital heart block. Report of 35 cases.Heart, 1982